
Worked on EnzymeAD/Reactant.jl over six months, delivering features and fixes focused on build automation, CI/CD reliability, and high-performance computing. Improved MLIR bindings workflows and artifact handling in CI, ensuring reproducible builds across Linux and macOS. Enhanced platform targeting by introducing explicit x86_64 Linux build constraints and stabilized symbol exports in the build system using C++ and Julia. Developed MLIR MPI dialect bindings to enable distributed simulations and evolved the tensor contraction API, optimizing performance and type inference. Emphasized code cleanup, refactoring, and workflow automation, leveraging technologies such as Bazel, GitHub Actions, and Julia package management throughout.
Monthly summary for EnzymeAD/Reactant.jl - May 2025: Focused on API evolution and performance improvements for tensor contractions. Delivered the Dot_general API evolution with einsum transitional support, deprecating the old einsum path in favor of dot_general, and providing a transitional einsum function for compatibility. Reverted prior despecialization to restore a stable, MLIR-based contraction path. Performance and type-inference improvements achieved by removing @noinline and adding Base.@nospecializeinfer and @nospecialize, enabling more efficient compilation and inference. Commits: d6e7b21a55c4f2fd9aec4a7666d1f89be817cad9 (Despecialize Ops.dot_general) and 45cec8d02b70f1d929ff229b59f692cec40942f3 (Revert 'Despecialize Ops.dot_general').
Monthly summary for EnzymeAD/Reactant.jl - May 2025: Focused on API evolution and performance improvements for tensor contractions. Delivered the Dot_general API evolution with einsum transitional support, deprecating the old einsum path in favor of dot_general, and providing a transitional einsum function for compatibility. Reverted prior despecialization to restore a stable, MLIR-based contraction path. Performance and type-inference improvements achieved by removing @noinline and adding Base.@nospecializeinfer and @nospecialize, enabling more efficient compilation and inference. Commits: d6e7b21a55c4f2fd9aec4a7666d1f89be817cad9 (Despecialize Ops.dot_general) and 45cec8d02b70f1d929ff229b59f692cec40942f3 (Revert 'Despecialize Ops.dot_general').
February 2025 monthly summary for EnzymeAD/Reactant.jl: Delivered MLIR MPI Dialect Bindings enabling MPI interactions from Julia. Established build-time support with MPIIncJLGen target and registered MPI.jl for binding generation. This work paves the way for high-performance, distributed simulations in Reactant.jl by enabling direct MPI usage from Julia, reducing friction for multi-node experiments.
February 2025 monthly summary for EnzymeAD/Reactant.jl: Delivered MLIR MPI Dialect Bindings enabling MPI interactions from Julia. Established build-time support with MPIIncJLGen target and registered MPI.jl for binding generation. This work paves the way for high-performance, distributed simulations in Reactant.jl by enabling direct MPI usage from Julia, reducing friction for multi-node experiments.
January 2025 monthly summary for EnzymeAD/Reactant.jl: focus on code health and stability. No new user-facing features delivered this month; major activity centered on cleaning up MLIR bindings to prevent confusion and binding errors, setting a stable foundation for upcoming work. The changes reduce maintenance risk and improve build reliability.
January 2025 monthly summary for EnzymeAD/Reactant.jl: focus on code health and stability. No new user-facing features delivered this month; major activity centered on cleaning up MLIR bindings to prevent confusion and binding errors, setting a stable foundation for upcoming work. The changes reduce maintenance risk and improve build reliability.
December 2024 monthly summary for EnzymeAD/Reactant.jl: Implemented a critical fix to symbol exports for ReactantExtra, ensuring correct exposure of RegisterCustomCallTarget and ConvertLLVMToMLIR in the BUILD system, preventing build/export failures. Completed release housekeeping: version bumped from 0.2.8 to 0.2.9 and Manifest-v*.toml ignored to keep manifests out of version control. These changes improve build stability, reproducibility, and release hygiene, enabling reliable CI and smoother onboarding for contributors.
December 2024 monthly summary for EnzymeAD/Reactant.jl: Implemented a critical fix to symbol exports for ReactantExtra, ensuring correct exposure of RegisterCustomCallTarget and ConvertLLVMToMLIR in the BUILD system, preventing build/export failures. Completed release housekeeping: version bumped from 0.2.8 to 0.2.9 and Manifest-v*.toml ignored to keep manifests out of version control. These changes improve build stability, reproducibility, and release hygiene, enabling reliable CI and smoother onboarding for contributors.
November 2024: Platform targeting improvements for EnzymeAD/Reactant.jl focused on Linux x86_64. Delivered explicit build constraints to ensure correct compilation and deployment workflows on x86_64 Linux, strengthening CI/CD reliability and cross-platform support.
November 2024: Platform targeting improvements for EnzymeAD/Reactant.jl focused on Linux x86_64. Delivered explicit build constraints to ensure correct compilation and deployment workflows on x86_64 Linux, strengthening CI/CD reliability and cross-platform support.
October 2024 monthly summary for EnzymeAD/Reactant.jl: Delivered CI/workflow improvements enabling reliable MLIR bindings regeneration, hardened artifact fetch in read-only CI filesystems, and corrected Julia depot path handling in Bazel-based workflows. Result: reduced CI failures, faster feedback, and more reproducible builds across Linux/macOS runners. Technologies leveraged include Julia, MLIR, Bazel, and GitHub Actions, with strong emphasis on package management, environment handling, and CI reliability.
October 2024 monthly summary for EnzymeAD/Reactant.jl: Delivered CI/workflow improvements enabling reliable MLIR bindings regeneration, hardened artifact fetch in read-only CI filesystems, and corrected Julia depot path handling in Bazel-based workflows. Result: reduced CI failures, faster feedback, and more reproducible builds across Linux/macOS runners. Technologies leveraged include Julia, MLIR, Bazel, and GitHub Actions, with strong emphasis on package management, environment handling, and CI reliability.

Overview of all repositories you've contributed to across your timeline